Статья

Endothelial dysfunction in COVID-19 patients and clinical application of laser therapy

A. Kochetkov, N. Ponomareva, N. Kadnikova, V. Mitkovskij, E. Yampolskaya, V. Lazarev,
2020

This review covers the published papers describing endothelial dysfunction pathogenesis and molecular mechanisms behind the effect of low-level laser therapy on regulation of the said pathogenesis. Herein, we present the current experience of using laser therapy to prevent development of endothelial dysfunction in the context of post-COVID-19 rehabilitation, as well as the accumulated data on the methods of combination of external or intravenous laser blood therapy and influence on the immunocompetent. We provide justification for practicing personalized approach at various stages of post-COVID-19 rehabilitation and treatment. The basis allowing greater efficacy of post-COVID-19 rehabilitation, including protocols making use of laser therapy, is the analysis of single-nucleotide polymorphisms of genes that determine adaptation processes, peculiarities of the immune response to infectious pathogens, predisposition to the development of respiratory distress syndrome, severe pneumonia, sepsis, multiple organ failure, development of endothelial dysfunction, thrombotic complications, the analysis that allows identification of patients running higher risk of critical conditions.

Цитирование

Похожие публикации

Версии

  • 1. Version of Record от 2020-12-18

Метаданные

Об авторах
  • A. Kochetkov
    Academy of Postgraduate Education FNSC FMBA of Russia, Moscow, Russia; Central Clinical Hospital for the Rehabilitation of FMBA of Russia, Solnechnogorsk District, Moscow Region, Russia
  • N. Ponomareva
    Central Clinical Hospital for the Rehabilitation of FMBA of Russia, Solnechnogorsk District, Moscow Region, Russia
  • N. Kadnikova
    Central Clinical Hospital for the Rehabilitation of FMBA of Russia, Solnechnogorsk District, Moscow Region, Russia
  • V. Mitkovskij
    Academy of Postgraduate Education FNSC FMBA of Russia, Moscow, Russia; Central Clinical Hospital for the Rehabilitation of FMBA of Russia, Solnechnogorsk District, Moscow Region, Russia
  • E. Yampolskaya
    Central Clinical Hospital for the Rehabilitation of FMBA of Russia, Solnechnogorsk District, Moscow Region, Russia
  • V. Lazarev
    Central Clinical Hospital for the Rehabilitation of FMBA of Russia, Solnechnogorsk District, Moscow Region, Russia
Название журнала
  • Bulletin officiel
Выпуск
  • (4)2020
Издатель
  • Federal Medical Biological Agency
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • dimensions